Status:
COMPLETED
Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients
Lead Sponsor:
KU Leuven
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Brief Summary
An evaluation of the effects of genetically determined variant metabolizing and transporting proteins involved in the disposition of the immunosuppressive drug tacrolimus in renal transplant recipient...
Detailed Description
A 5-year pharmacokinetic follow-up study in 95 renal allograft recipients assessing tacrolimus exposure using repeated abbreviated Area-Under-the-Concentration-time (AUC) curve measurements at regular...
Eligibility Criteria
Inclusion
- Primary or secondary single kidney transplantation
- Age older than 18 yrs
Exclusion
- Combined organ transplantation
Key Trial Info
Start Date :
August 1 1999
Trial Type :
OBSERVATIONAL
End Date :
September 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00411944
Start Date
August 1 1999
End Date
September 1 2005
Last Update
December 15 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephology and Renal Transplantation
Leuven, Belgium, B-3000